PDCD1 and pneumococcal infection: McKay et al. [18] found that PD-1−/− mice, as well as wild type mice treated with a PD-1-blocking antibody, exhibited significantly increased survival against lethal Streptococcus pneumoniae infection following either priming with low-dose pneumococcal respiratory infection or S. pneumoniae-capsular polysaccharide immunization.